129 results
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
15 Feb 24
Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
7:03am
and $2.9 million for the full year ended Dec. 31, 2023.
Research and Development (R&D) Expenses: R&D expenses were $77.5 million for the fourth quarter … revenue
Operating expenses
Cost of sales
Research and development
Selling, general and administrative
Total operating expenses
Loss from operations
Gain
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
2 Nov 23
Agios Reports Business Highlights and Third Quarter 2023 Financial Results
7:02am
revenue, net
Milestone revenue
Total revenue
Operating expenses:
Cost of sales
Research and development
Selling, general and administrative
Total … , compared to $3.5 million for the third quarter of 2022.
Cost of Sales: Cost of sales for the third quarter of 2023 was $0.6 million.
Research
8-K
EX-99.1
pav8ji20u6o hfe25n
3 Aug 23
Agios Reports Business Highlights and Second Quarter 2023 Financial Results
6:38am
S-8
EX-99.1
by2fxb
13 Jun 23
Registration of securities for employees
4:13pm
8-K
EX-99.1
oyn3 k530t
4 May 23
Agios Reports Business Highlights and First Quarter 2023 Financial Results
7:03am
8-K
EX-99.1
c4w1epnme 4ran3igj7r
3 Nov 22
Agios Reports Business Highlights and Third Quarter 2022 Financial Results
7:02am
8-K
EX-99.1
bv5mjny
4 Aug 22
Agios Reports Business Highlights and Second Quarter 2022 Financial Results
7:14am
8-K
EX-99.1
gpezlye aw5el
5 May 22
Agios Reports Business Highlights and First Quarter 2022 Financial Results
7:21am